MAALOX

200/175 MG/5ml Oral Suspension

Sanofi-Aventis Ireland Limited T/A SANOFIPA0540/110/001

Marketing Status

24 Feb 2016 - 15 Feb 201715 Feb 2017 - Present
Temporarily Not MarketedMarketed
« Back

Latest Changes to Medicine Info & SPC


Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.